DecisionGateway
Feed Claims Forecasts Domains Calendar Actors Places Labs
Beta
API Sign in
HomeClaimsThe company plans to seek U.S. approval for this indication by year-end.
commitment

The company plans to seek U.S. approval for this indication by year-end.

A commitment by Lilly. Statements are as reported by the cited publishers — not verified by DecisionGateway.

the company plans to seek U.S. approval for this indication by year-end
pattystraphousePublished 2026-11-09 Read source

Discussion

0/2000 Ctrl/⌘ + Enter

Related claims

The Government plans to approve it before the end of the year.El Gobierno · commitmentThe matter still requires approval by the company's 2026 年第四次临时股东会.*ST 启环 · statementThe approval is valid until March 2031.shipping00 · statementThe company is also considering the possibility of supplies from the United States and other Western states.rustorgpred · statement在2026年10月13日或之后提交的申请将不会被受理,直至另行通知。汇丰香港 · predictionThe company expects to take a final investment decision (FID) before the end of 2027.Компания · prediction
All claims
FeedActorsForecasts